Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part II. Diagnosis and Management.

DHR DRESS DiHS SCAR delayed hypersensitivity reaction drug rash drug reaction drug reaction with eosinophilia and systemic symptoms drug-induced hypersensitivity syndrome eosinophilia exanthem exanthematous drug eruption hypersensitivity maculopapular eruption morbilliform eruption severe cutaneous adverse drug reaction

Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
27 Jul 2023
Historique:
received: 28 09 2022
revised: 11 02 2023
accepted: 17 02 2023
medline: 30 7 2023
pubmed: 30 7 2023
entrez: 29 7 2023
Statut: aheadofprint

Résumé

Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction (SCAR) characterized by an exanthem, fever, and hematologic and visceral organ involvement. The differential diagnosis includes other cutaneous adverse reactions, infections, inflammatory and autoimmune diseases, and neoplastic disorders. Three sets of diagnostic criteria have been proposed; however, consensus is lacking. The cornerstone of management is immediate discontinuation of the suspected drug culprit. Systemic corticosteroids remain first-line therapy, but the literature on steroid-sparing agents is expanding. Longitudinal evaluation for sequelae is recommended. Adjunctive tests for risk stratification and drug culprit identification remain under investigation. Part II of this continuing medical education activity begins by exploring the differential diagnosis and diagnosis of DiHS/DRESS and concludes with an evidence-based overview of evaluation and treatment.

Identifiants

pubmed: 37516356
pii: S0190-9622(23)02403-9
doi: 10.1016/j.jaad.2023.02.073
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Brian M Wei (BM)

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

Lindy P Fox (LP)

Department of Dermatology, University of California, San Francisco, California.

Benjamin H Kaffenberger (BH)

Department of Dermatology, The Ohio State University, Columbus, Ohio.

Abraham M Korman (AM)

Department of Dermatology, The Ohio State University, Columbus, Ohio.

Robert G Micheletti (RG)

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Arash Mostaghimi (A)

Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Megan H Noe (MH)

Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Misha Rosenbach (M)

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Kanade Shinkai (K)

Department of Dermatology, University of California, San Francisco, California.

Jason H Kwah (JH)

Department of Medicine, Section of Rheumatology, Allergy and Immunology, Yale School of Medicine, New Haven, Connecticut.

Elizabeth J Phillips (EJ)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Jean L Bolognia (JL)

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

William Damsky (W)

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

Caroline A Nelson (CA)

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: Caroline.Nelson@yale.edu.

Classifications MeSH